1 completed, 1 not yet recruiting, 1 terminated. 2 Phase 2, 1 Phase 1.
| Phase | Trials | Status |
|---|---|---|
| Phase 2 | 2 | Completed 1, Not yet recruiting 1 |
| Phase 1 | 1 | Terminated 1 |
Follow Metastatic Myxoid Liposarcoma: new trials by email Literature Review of Metastatic Myxoid Liposarcoma trials Research Report on Metastatic Myxoid Liposarcoma
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Testing the Anti-Cancer Drug, Brenetafusp (IMCF106C), in Rare Cancers Anti-PRAME T-cell Receptor/Anti-CD3 scFv Fusion Protein IMC-F106C, Biopsy Procedure, Biospecimen Collection - Metastatic Myxoid Liposarcoma, Metastatic Synovial Sarcoma | Phase 2 | Not yet recruiting | National Cancer Institute (NCI) | 42 | 2026-11-23 | 2026-09-25 |
| Itacitinib in Treating Patients With Refractory Metastatic/Advanced Sarcomas Itacitinib, Laboratory Biomarker Analysis - Metastatic Leiomyosarcoma, Metastatic Synovial Sarcoma | Phase 1 | Terminated | Fred Hutchinson Cancer Center | 27 | 2019-09-30 | 2024-05-08 |
| Testing the Combination of Two Experimental Drugs MK-3475 (Pembrolizumab) and Interferon-gamma for the Treatment of Mycosis Fungoides and Sézary Syndrome and Advanced Synovial Sarcoma Interferon Gamma-1b, Laboratory Biomarker Analysis, Pembrolizumab - Metastatic Myxoid Liposarcoma, Metastatic Round Cell Liposarcoma | Phase 2 | Completed | National Cancer Institute (NCI) | 28 | 2017-12-14 | 2023-10-25 |
Liposarcoma, Myxoid (3) · Sarcoma, Synovial (3) · Chondrosarcoma (1) · Histiocytoma, Malignant Fibrous (1) · Leiomyosarcoma (1) · Mycosis Fungoides (1) · Sarcoma (1) · Sezary Syndrome (1)
Liposarcoma (3) · Neoplasms (3) · Neoplasms by Histologic Type (3) · Neoplasms, Adipose Tissue (3) · Neoplasms, Connective Tissue (3) · Neoplasms, Connective and Soft Tissue (3) · Sarcoma (2) · Hemic and Lymphatic Diseases (1) · Histiocytoma (1) · Immune System Diseases (1) · Immunoproliferative Disorders (1) · Lymphatic Diseases (1) · Lymphoma (1) · Lymphoma, Non-Hodgkin (1) · Lymphoma, T-Cell (1)
Biopsy (1) · INCB039110 (1) · Interferon-gamma (1) · Magnetic Resonance Spectroscopy (1) · Specimen Handling (1) · baricitinib (1) · interferon gamma-1b (1) · itacitinib (1) · pembrolizumab (1)
National Cancer Institute (NCI) (2) · Fred Hutchinson Cancer Center (1)
United States (2)
Lee Cranmer (1) · Michael S Khodadoust, MD (1) · Michael Wagner (1)
P30CA015704 (1), U01CA154967 (1), UM1CA186709 (1)